We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Further Data from First Clinical Trial of ReNeuron’s Stem Cell Therapy to be Presented at Stroke Conference

News   May 16, 2014

 
Further Data from First Clinical Trial of ReNeuron’s Stem Cell Therapy to be Presented at Stroke Conference
 
 
 

RELATED ARTICLES

Ebola Patients Have a 90% Survival Rate After Injection With New Drugs

News

Two Ebola drugs have proven so effective in a clinical trial that researchers will make the treatments available to anyone infected with the virus in the Democratic Republic of the Congo, where Ebola has killed nearly 1,900 people over the past year.

READ MORE

Drug for Rare Disease in Which Patients Can't Eat Fat

News

A research team has tested how well the drug volanesorsen reduces fat accumulation in the blood of participants with familial chylomicronemia syndrome. People with familial chylomicronemia syndrome are born with a genetic mutation that means they can't produce an enzyme called lipoprotein lipase. Therefore their bodies can't break down dietary-derived fat in the blood.

READ MORE

World First: Phase 1 Trial of Chlamydia Vaccine Finds That It Is Safe and Provokes Immune Response

News

The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response, according to a new study.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE